Methylene steroids as novel androgens

Details for Australian Patent Application No. 2002224923 (hide)

Owner N.V. Organon

Inventors Leysen, D.; Van Der Louw, J.; De Gooijer, M. E.

Agent Spruson & Ferguson

Pub. Number AU-B-2002224923

PCT Pub. Number WO02/48171

Priority 00204459 11.12.00 EP

Filing date 5 December 2001

Wipo publication date 24 June 2002

Acceptance publication date 4 January 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

A61P 15/16 (2006.01) Drugs for genital or sexual disorders

C07J 53/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

Event Publications

2 November 2006 Assignment before Grant

  Akzo Nobel N.V. The application has been assigned to N.V. Organon

4 January 2007 Application Accepted

  Published as AU-B-2002224923

3 May 2007 Standard Patent Sealed

22 December 2011 Alteration of Name

  The name of the patentee has been altered to MSD Oss B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002224924

2002224922-Liquid yeast compositions